Veeva Systems R&D Solutions — Total revenues decreased by 1.1% to $81.28M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 12.1%, from $72.50M to $81.28M. Over 2 years (FY 2023 to FY 2025), R&D Solutions — Total revenues shows an upward trend with a 6.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates growing adoption of the company's R&D software suite and successful expansion within the life sciences customer base, while a decrease may signal market saturation or increased competitive pressure in the clinical and regulatory software space.
This metric represents the total revenue generated from subscription services and cloud-based software solutions specifi...
Comparable to vertical-specific SaaS revenue metrics for enterprise software providers serving highly regulated industries, often benchmarked against other health-tech or life sciences software peers.
veev_segment_r_d_solutions_total_revenues| Q1 '21 | Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $133.27M | $148.31M | $53.70M | $59.15M | $61.15M | $65.50M | $59.08M | $66.92M | $72.27M | $73.69M | $63.22M | $67.62M | $69.84M | $72.50M | $66.70M | $77.71M | $82.20M | $81.28M |
| QoQ Change | — | +11.3% | -63.8% | +10.2% | +3.4% | +7.1% | -9.8% | +13.3% | +8.0% | +2.0% | -14.2% | +7.0% | +3.3% | +3.8% | -8.0% | +16.5% | +5.8% | -1.1% |
| YoY Change | — | — | — | -55.6% | -58.8% | +22.0% | — | +13.1% | +18.2% | +12.5% | +7.0% | +1.1% | -3.4% | -1.6% | +5.5% | +14.9% | +17.7% | +12.1% |